Interested in Semaglutide?

How to Understand Semaglutide Dosing Chart

A doctor holding a clipboard explains a medication dosing plan to a woman in a clinical office, both reviewing information together.

So, your healthcare provider has prescribed semaglutide, and now you’re looking at a dosing chart. We get it—those numbers and schedules can feel confusing at first glance. Don’t worry, you’re not alone. Think of this guide as your helpful friend, here to walk you through your dosing chart step-by-step. We’ll explain why the dose increases slowly, what all those numbers really mean, and how you can follow your schedule safely and effectively.

Active Ingredient: Semaglutide

Semaglutide activates glucagon-like peptide-1 (GLP-1) receptors, helping control appetite, slow gastric emptying, and regulate blood sugar. The result: reduced calorie intake and improved satiety, which lead to sustained weight loss.

Semaglutide is available in three FDA-approved formulations:

Brand Name Manufacturer Route FDA-Approved Use FDA Approval Year
Ozempic Novo Nordisk Injectable (weekly) Type 2 diabetes; Cardiovascular risk reduction 2017
Wegovy Novo Nordisk Injectable (weekly) Chronic weight management 2021
Rybelsus (oral) Novo Nordisk Oral Tablet (daily tablet) Type 2 diabetes 2019

Throughout this article, any reference to semaglutide for weight loss refers to Wegovy. Mentions of semaglutide for blood sugar control refer to Ozempic.

What is a Semaglutide Dosing Chart and Why Does It Matter?

Simply put, a semaglutide dosing chart is your personal roadmap. It visually lays out exactly how much medicine to take and when you’ll take it. The chart shows a gradual increase (called titration) over several weeks or months.

Understanding this roadmap is super important because you don’t start at the full dose right away. Instead, starting low and going slow is a standard strategy that helps your body adjust gently. This approach can significantly minimize common side effects like nausea. By following your chart precisely, you help ensure you get the intended benefits while staying comfortable.

The Logic Behind “Starting Low and Going Slow”

Think of starting semaglutide not as flipping a light switch, but as slowly turning up a dimmer. Your body, especially your digestive system, needs a little time to get used to the medication’s effects.

  • Starting Low (e.g., 0.25 mg): We like to call this the “welcome dose.” Its main job is to introduce the medication to your system very gently, letting your body acclimate with minimal fuss.

  • Gradual Increases: After about 4 weeks at the starting dose, your chart will typically guide you to a slightly higher one (e.g., 0.5 mg). This step-up approach carefully balances two things: increasing the medication’s effectiveness while continuing to keep an eye on your comfort.

  • Reaching Your Maintenance Dose: Finally, the chart leads you to your target “maintenance dose.” This is the level that clinical studies found to be optimal. Remember, this slow and steady process is the cornerstone of safe and effective treatment.

How to Read Your Semaglutide Dosing Chart

Most charts are pretty straightforward and organized by week, dose, and how often you inject. Let’s break down a standard format together.

Here’s what you’ll usually find on your chart:

  • Week/Time Period: This tells you how long you stay at each dose level.

  • Dose (mg): This is the amount of semaglutide, measured in milligrams (mg). It’s the most important number to track!

  • Frequency: This is almost always once per week. Consistency is key here—giving yourself the injection on the same day each week helps maintain steady medication levels in your body.

Here’s an example of what a typical titration schedule looks like:

Week Dose (mg) Frequency Purpose
1 to 4 0.25 mg Once weekly Your gentle starting dose
5 to 8 0.5 mg Once weekly Your first step up
9 to 12 1.0 mg Once weekly A further increase
13 to 16 1.7 mg Once weekly Nearing your maintenance dose (for Wegovy®)
17+ 2.4 mg Once weekly Your maintenance dose for weight management (for Wegovy®)

Please remember: This is just an example. You should always follow the specific chart your own healthcare provider gives you.

Ozempic®, Wegovy®, and Compounded Semaglutide: How Their Charts Differ

While Ozempic® and Wegovy® both contain the active ingredient semaglutide, the FDA has approved them for different uses, so their dosing schedules aren’t the same. It’s really important to follow the chart specifically for the medication you are prescribed.

Ozempic® (semaglutide) Dosing Chart

  • Main Use: Doctors prescribe it to improve blood sugar control in adults with type 2 diabetes.

  • Dosing Schedule: The maintenance dose for Ozempic is usually 1.0 mg once weekly. A 2.0 mg dose is also an option if needed for further blood sugar control.

Week Dose (mg) Frequency
1 to 4 0.25 mg Once weekly
5 to 8 0.5 mg Once weekly
9+ 1.0 mg Once weekly
May be increased to 2.0 mg Once weekly

 

Wegovy® (semaglutide) Dosing Chart

  • Main Use: Doctors prescribe it for chronic weight management.

  • Dosing Schedule: Wegovy uses a longer, more gradual titration up to a 2.4 mg weekly maintenance dose, which was the dose studied for weight management.

Week Dose (mg) Frequency
1 to 4 0.25 mg Once weekly
5 to 8 0.5 mg Once weekly
9 to 12 1.0 mg Once weekly
13 to 16 1.7 mg Once weekly
17+ 2.4 mg Once weekly

Compounded Semaglutide Dosing Chart (Illustrative Example)

With compounded semaglutide, your provider may follow a dosage progression similar to standard schedules. However, the final medication comes as a vial of liquid, and you draw the prescribed dose into a syringe. Your dose in milligrams (mg) remains the focus, but the volume you draw in milliliters (mL) or “units” depends entirely on the vial’s concentration.

The chart below shows a typical progression alongside a critical conversion example:

Weekly Dosage Progression (mg) Purpose Injection Volume Example* (if concentration is 2.5 mg/mL)
Weeks 1-4: 0.25 mg Starting dose to help your body adjust. 0.1 mL
Weeks 5-8: 0.5 mg First increase for enhanced effect. 0.2 mL
Weeks 9+: 1.0 mg Common maintenance dose for weight management. 0.4 mL
May increase to: 2.0 mg Higher maintenance dose, if needed and tolerated. 0.8 mL

*This is a hypothetical example. Your actual injection volume will be calculated by your provider and pharmacy based on the specific concentration of your compounded vial (e.g., 2.5 mg/mL, 5 mg/mL, etc.).

  • The dose in milligrams (mg) is never equal to the volume in milliliters (mL). Your provider and pharmacy must give you a customized chart showing exactly how much liquid to draw for your specific dose.

  • Always follow your personalized instructions. Serious dosing errors, including accidental overdoses, can occur if you confuse mg and mL or use the wrong syringe.

Important Note on Compounded Semaglutide
  • Important Clarification: The FDA-approved brands Ozempic® and Wegovy® are NOT compounded drugs. “Compounded” semaglutide means a specialty pharmacy prepares the medication.

  • Key Difference: If you receive a compounded formula, its concentration might differ from brand-name pens. Because of this, you must follow the dosing chart from your provider and that specific pharmacy. Never assume the dose in “mg” equals the volume in “mL” to draw into a syringe.

Common Dosing Chart Mistakes (and How to Avoid Them!)

Knowing about these common mix-ups can help you avoid under-dosing, over-dosing, or unnecessary side effects.

  1. Mixing Up Milligrams (mg) and Milliliters (mL): This is the big one! mg is the amount of medication. mL is the volume of liquid that contains it. Your chart gives you the dose in mg. If you use a vial and syringe, separate instructions will tell you how many mL to draw up to get that correct mg dose.

  2. Misreading the Weekly Timeline: The chart moves forward sequentially. You don’t repeat the “Weeks 1-4” dose every month. Instead, after you finish those 4 weeks, you move to the next dose level.

  3. Using the Wrong Brand’s Chart: If you use an Ozempic® chart for Wegovy®, you’ll follow the wrong timeline. Always double-check you’re looking at the right one.

  4. Changing Your Dose or Schedule on Your Own: We know it’s tempting to increase the dose if you feel it’s “not working” yet, but please don’t. Your provider designed the timeline to let your body adapt safely. Always check with them before making any changes.

What If You Miss a Dose or Have Side Effects?

  • If You Forget a Dose: Here’s the simple rule: If you remember within 5 days (120 hours) of your injection day, go ahead and take it as soon as you can. If more than 5 days have passed, just skip that missed dose and take your next one on your regular scheduled day. Never take two doses to make up for one you missed.

  • Managing Side Effects: It’s pretty common to feel some mild nausea, fatigue, or constipation, especially early on or after a dose increase. The good news is, this usually gets better as your body adjusts. Try eating smaller, blander meals and drinking plenty of water to help with nausea. However, if side effects are severe, persistent, or you get severe stomach pain, contact your healthcare provider right away. And remember, never change your dose to try and manage side effects on your own—always talk to your provider first.

Your Key Takeaways

Think of your semaglutide dosing chart as a trusted, carefully designed guide. Its “start low, go slow” method is a smart, scientific way to help your body adapt while working toward your goals. Starting at 0.25 mg weekly and titrating slowly to 2.4 mg allows your body to adapt and your results to stabilize. Now that you know how to tell mg from mL, how to follow the right chart, and why consistency matters, you’re all set to use your roadmap with confidence.

Whether you use injectable or oral semaglutide, consistency and professional oversight are essential.

Heally can connect you to a knowledgeable doctor who can help you find the best way forward with Semaglutide. You don’t have to navigate this alone; let’s find the right solution together, schedule your free consultation with Heally today!

Sources

  1. NIH: Semaglutide StatPearls
  2. New England Journal of Medicine – STEP 1 Trial: Once‑Weekly Semaglutide for Weight Loss
  3. Nature – Two-Year Effects of Semaglutide (STEP 5 Trial)
  4. FDA Alert – Overdose Risks from Semaglutide and Other GLP-1 Agonists
  5. WEGOVY – Wegovy Dosing Schedule
  6. Drugs: Rybelsus Dosage
  7. Ozempic: A Once Weekly Dosing Schedule
Semaglutide FDA Labels:
  1. FDA Label: OZEMPIC (Semaglutide Injection) Medication Guide
  2. FDA Label: WEGOVY (Semaglutide Injection) Medication Guide
  3. FDA Label: RYBELSUS (Oral Semaglutide) Medication Guide
Tirzepatide FDA Labels:
  1. FDA Label: MOUNJARO (Tirzepatide Injection) Medication Guide
  2. FDA Label: ZEPBOUND (Tirzepatide Injection) Medication Guide

Important Medical Information and Disclaimers

MEDICAL DISCLAIMER

This information is for educational purposes only and is not intended as medical advice, diagnosis, or treatment recommendation. Semaglutide is the active ingredient in three FDA-approved prescription medications: Ozempic and Rybelsus, approved for improving blood sugar control in adults with type 2 diabetes, and Wegovy, approved for chronic weight management in adults with obesity or overweight who have at least one weight-related medical condition. Although these medications contain semaglutide, they are approved for different uses and have different dosing schedules. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment plan.

INDIVIDUAL RESULTS VARY

Outcomes with semaglutide treatment vary from person to person. Clinical trial data may not reflect typical real-world experiences. A variety of factors can affect your results, including medication adherence, lifestyle habits such as diet and exercise, metabolic differences, other health conditions, and concurrent medications. No specific result is guaranteed.

IMPORTANT SAFETY INFORMATION

Common side effects of semaglutide may include: Nausea, Vomiting, Diarrhea, Constipation, Stomach pain, Decreased appetite, Indigestion, Belching or gas, Injection site reactions

These side effects are often mild and may lessen over time. Always inform your healthcare provider about any medical conditions, allergies, and all medications you are currently taking before starting semaglutide. Ongoing monitoring is recommended during treatment.

WARNING: Semaglutide has a boxed warning about the potential risk of thyroid C-cell tumors. Do not use this medication if you or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

FDA ADVERSE EVENT REPORTING

You are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA).
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Adverse events may also be reported directly to the manufacturer.

 

Interested in alternative treatment options? Check out our different services.
Get $100 Off First Month's Medication
Explore Semaglutide for Weight Management
0 Shares: